| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer &EVP | Interim Co-ceo And CFO | Chief Financial Officer +2 more
2 companies
Andrews Deborah J is a Chief Financial Officer &EVP at STAA, with reported holdings spanning 2 companies. Recent filings cover 5 purchases and 8 sales. Those positions are worth an estimated $46K at current prices.
Andrews Deborah J's largest disclosed position is in LCTX, worth about $46K. The recent filings there lean toward selling, a net 9,142 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2017 | LCTX Lineage Cell Therapeutics, Inc. | Director | Buy | 2,000 | $2.95 | $5,900.00 | +50.0% | |
| May 16, 2017 | LCTX Lineage Cell Therapeutics, Inc. | Director | Buy | 2,000 | $3.21 | $6,410.40 | +100.0% | |
| Aug 26, 2015 | LCTX Lineage Cell Therapeutics, Inc. | Director | Buy | 2,000 | $2.82 | $5,640.00 | New |